BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 959779)

  • 1. Cell-mediated cytotoxicity for melanoma tumor cells: detection by a (3H) proline release assay.
    Saal JG; Rieber EP; Riethmüller G
    Scand J Immunol; 1976; 5(5):455-66. PubMed ID: 959779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective and non-selective lymphocytotoxicity in human melanoma: observation on the effect of long-term culture and fetal bovine serum on target-cell sensitivity to lymphocytes.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Int J Cancer; 1975 Dec; 16(6):971-80. PubMed ID: 53212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte cytotoxicity of patients developing multiple primary melanomas.
    Mukherji B; Dayal Y
    Cancer; 1980 Oct; 46(7):1566-71. PubMed ID: 6968241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
    Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
    Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular microcytotoxicity in human tumor systems: analysis of results.
    Oldham RK; Djeu JY; Cannon GB; Siwarski D; Herberman RB
    J Natl Cancer Inst; 1975 Dec; 55(6):1305-18. PubMed ID: 54436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro assay of spontaneous cytotoxicity by human monocytes and macrophages against tumor cells.
    Mukherji B
    J Immunol Methods; 1980; 37(3-4):233-47. PubMed ID: 7451996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated cytotoxicity for cultured autologous melanoma cells.
    Livingston PO; Shiku H; Bean MA; Pinsky CM; Oettgen HF; Old LJ
    Int J Cancer; 1979 Jul; 24(1):34-44. PubMed ID: 478690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 51Cr release and microcytotoxicity assays against human melanoma cells.
    Hersey P; Edwards J; Edwards A; Adams E; Kearney R; Milton GW
    Int J Cancer; 1975 Jul; 16(1):164-72. PubMed ID: 1080748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent cell-mediated cytotoxicity for human monolayer target cells bearing blood group and transplantation antigens and for melanoma cells.
    Kodera Y; Bean MA
    Int J Cancer; 1975 Oct; 16(4):579-92. PubMed ID: 1080751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,
    de Vries JE; Cornain S; Rumke P
    Int J Cancer; 1974 Oct; 14(4):427-34. PubMed ID: 4549213
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte mediated reactivity against malignant melanoma detected by a microcytotoxicity assay employing technetium-99m labeled target cells.
    Gillespie GY; Barth RF
    Cancer; 1978 Jun; 41(6):2174-82. PubMed ID: 350374
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells.
    Ting CC; Nunn ME; Park JY; Herberman RB
    J Natl Cancer Inst; 1977 Feb; 58(2):331-7. PubMed ID: 833881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro cell-mediated immune reactions of melanoma and colorectal carcinoma patients demonstrated by long-term 51chromium assays.
    Steele G; Sjögren HO; Stadenberg I
    Int J Cancer; 1976 Jan; 17(1):27-39. PubMed ID: 1248900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
    Peter HH; Knoop F; Kalden JR
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of natural cytotoxicity and the leukocyte migration inhibition in human melanoma stages I and II.
    Kristensen E
    J Cancer Res Clin Oncol; 1980; 96(2):181-91. PubMed ID: 7391115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays.
    Steele G; Sjögren HO; Lannerstad O; Stadenberg I
    Int J Cancer; 1975 Oct; 16(4):682-93. PubMed ID: 1176212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
    Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
    J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator.
    Peter HH; Eife RF; Kalden JR
    J Immunol; 1976 Feb; 116(2):342-8. PubMed ID: 1082453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Position-dependent cell survival and the microcytotoxicity assay.
    Chalmers PJ; Pullen GR; Nind AP; Nairn RC
    J Immunol Methods; 1982; 51(1):81-8. PubMed ID: 7108230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.